All of our treatments, including IV vitamin therapy drips, are in line with the core principles of integrative functional medicine. We can tailor treatment plans for different wellness concerns, including sexual health, brain health, digestive health issues, heart disease, autoimmune illness, chronic disease management, and more. Our healthcare providers collaborate with patients in designing personalized care plans related to wellness. We find that open discussions on healthy living and patient education can inspire people to stick to their health goals!
Our functional medicine blends integrated health care so that you can discover other modalities for your optimal wellness; some of these include Western medicine, Traditional Chinese medicine, bio-Identical hormone replacement therapy, naturopathic medicine, and herbal medicine.
Revitalize your gut health through nutrition, disease prevention, and healthy lifestyle modifications! Our health coaching could provide new insights into your wellness. Click here to book your slot for functional medicine in our Toronto clinic.
Disclaimer: The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.
Allen AP, Hutch W, Borre YE et al (2016) Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry 6:e939–e939
Anand U, Yiangou Y, Akbar A et al (2018) Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons. PLoS ONE 13:e0198024
Ansari F, Pourjafar H, Tabrizi A, Homayouni A (2020) The effects of probiotics and prebiotics on mental disorders: a review on depression, anxiety, Alzheimer, and autism spectrum disorders. Curr Pharm Biotechnol 21:555–565
Athauda D, Foltynie T (2016) The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson’s disease: mechanisms of action. Drug Discov Today 21:802–818
Barichella M, Pacchetti C, Bolliri C et al (2016) Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT. Neurology 87:1274–1280
Bonfili L, Cecarini V, Gogoi O et al (2020) Gut microbiota manipulation through probiotics oral administration restores glucose homeostasis in a mouse model of Alzheimer’s disease. Neurobiol Aging 87:35–43. https://doi.org/10.1016/j.neurobiolaging.2019.11.004
Cassani E, Privitera G, Pezzoli G et al (2011) Use of probiotics for the treatment of constipation in Parkinson’s disease patients. Minerva Gastroenterol Dietol 57:117–121
Castelli V, d’Angelo M, Lombardi F et al (2020) Effects of the probiotic formulation SLAB51 in in vitro and in vivo Parkinson’s disease models. Aging (albany NY) 12:4641
Cloud LJ, Greene JG (2011) Gastrointestinal features of Parkinson’s disease. Curr Neurol Neurosci Rep 11:379–384
Dargahi N, Matsoukas J, Apostolopoulos V (2020) Streptococcus thermophilus ST285 alters pro-inflammatory to anti-inflammatory cytokine secretion against multiple sclerosis peptide in mice. Brain Sci 10:126
Del Toro-Barbosa M, Hurtado-Romero A, Garcia-Amezquita LE, García-Cayuela T. Psychobiotics: Mechanisms of Action, Evaluation Methods and Effectiveness in Applications with Food Products. Nutrients. 2020 Dec 19;12(12):3896. doi: 10.3390/nu12123896. PMID: 33352789; PMCID: PMC7767237.
Foster JA, Neufeld K-AM (2013) Gut–brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36:305–312
Georgescu D, Ancusa OE, Georgescu LA et al (2016) Nonmotor gastrointestinal disorders in older patients with Parkinson’s disease: is there hope? Clin Interv Aging 11:1601
Kim DS, Choi H-I, Wang Y et al (2017) A new treatment strategy for Parkinson’s disease through the gut–brain axis: the glucagon-like peptide-1 receptor pathway. Cell Transplant 26:1560–1571
Kim J-S, Sung H-Y (2015) Gastrointestinal autonomic dysfunction in patients with Parkinson’s disease. J Mov Disord 8:76
Kouchaki E, Tamtaji OR, Salami M et al (2017) Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr 36:1245–1249
Lyte M, Li W, Opitz N et al (2006) Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 89:350–357
Mohammadi AA, Jazayeri S, Khosravi-Darani K et al (2016) The effects of probiotics on mental health and hypothalamic–pituitary–adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr Neurosci 19:387–395
Morshedi M, Hashemi R, Moazzen S et al (2019) Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review. J Neuroinflammation 16:1–11
Oroojzadeh, P., Bostanabad, S.Y. & Lotfi, H. Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders. J Mol Neurosci 72, 1952–1964 (2022). https://doi.org/10.1007/s12031-022-02053-3
Sarkar A, Lehto SM, Harty S et al (2016) Psychobiotics and the manipulation of bacteria–gut–brain signals. Trends Neurosci 39:763–781
Tiller JWG (2013) Depression and anxiety. Med J Aust 199:S28–S31
Yong SJ, Tong T, Chew J, Lim WL (2020) Antidepressive mechanisms of probiotics and their therapeutic potential. Front Neurosci 13:1361